ArriVent BioPharma (AVBP) Change in Acquisitions & Divestments (2025 - 2026)

ArriVent BioPharma's (AVBP) quarterly Change in Acquisitions & Divestments came in at $68.0 million in Q1 2026, up 45.73% year-on-year from $46.6 million in Q1 2025, and down 15.02% quarter-over-quarter from $80.0 million in Q4 2025.

ArriVent BioPharma (AVBP) Change in Acquisitions & Divestments (2025 - 2026) Analysis & Trends

ArriVent BioPharma has disclosed Change in Acquisitions & Divestments across 2 years of filings, most recently posting $68.0 million for Q1 2026.

  • Change in Acquisitions & Divestments for Q1 2026 came in at $68.0 million, up 45.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $223.0 million (changed N/A YoY), and the FY2025 annual result was $201.7 million, up 11772.04% from the prior year.
  • Change in Acquisitions & Divestments came in at $68.0 million for Q1 2026 at ArriVent BioPharma, down from $80.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $80.0 million in Q4 2025 to a low of $35.5 million in Q2 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn -
7 Psyence Biomedical 227.32 Bn 227.31 Bn -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn
9 Abivax 91.71 Bn 91.71 Bn -
10 ArriVent BioPharma 1.37 Bn 1.37 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 67.97 Mn
Mar 31, 2026 67.97 Mn
Dec 31, 2025 79.98 Mn
Dec 31, 2025 79.98 Mn
Sep 30, 2025 39.61 Mn
Sep 30, 2025 39.61 Mn
Jun 30, 2025 35.48 Mn
Jun 30, 2025 35.48 Mn
Mar 31, 2025 46.64 Mn
Mar 31, 2025 46.64 Mn